<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">transplantologiya</journal-id><journal-title-group><journal-title xml:lang="ru">Трансплантология</journal-title><trans-title-group xml:lang="en"><trans-title>Transplantologiya. The Russian Journal of Transplantation</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-0506</issn><issn pub-type="epub">2542-0909</issn><publisher><publisher-name>IPO Association of Transplantologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.23873/2074-0506-2012-0-3-33-41</article-id><article-id custom-type="elpub" pub-id-type="custom">transplantologiya-349</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОБЛЕМНЫЕ АСПЕКТЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PROBLEMATIC ASPECTS</subject></subj-group></article-categories><title-group><article-title>Особенности формирования иммунного ответа на инфекцию, вызванную вирусами семейства Herpesviridae или вирусами гепатитов С и В, у пациентов после трансплантации печени</article-title><trans-title-group xml:lang="en"><trans-title>Features of formation of the immune response to infection caused by viruses of the Herpesviridae family or viruses of hepatitis C and B in patients after liver transplantation</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Никулина</surname><given-names>В. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Nikulina</surname><given-names>V. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Никулина Валентина Петровна</p></bio><email xlink:type="simple">sa-to@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андрейцева</surname><given-names>О. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Andreytseva</surname><given-names>O. I.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сюткин</surname><given-names>В. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Syutkin</surname><given-names>V. E.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Годков</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Godkov</surname><given-names>M. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чжао</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Сhzhao</surname><given-names>A. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ скорой помощи им. Н.В.Склифосовского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sklifosovsky Research Institute of Emergency Care</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>23</day><month>08</month><year>2018</year></pub-date><volume>0</volume><issue>3</issue><fpage>33</fpage><lpage>41</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Никулина В.П., Андрейцева О.И., Сюткин В.Е., Годков М.А., Чжао А.В., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Никулина В.П., Андрейцева О.И., Сюткин В.Е., Годков М.А., Чжао А.В.</copyright-holder><copyright-holder xml:lang="en">Nikulina V.P., Andreytseva O.I., Syutkin V.E., Godkov M.A., Сhzhao A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.jtransplantologiya.ru/jour/article/view/349">https://www.jtransplantologiya.ru/jour/article/view/349</self-uri><abstract><p>Наблюдали 44 пациента в первые 2–3 недели после трансплантации печени. В зависимости от течения послеоперационного периода пациентов разделили на три группы: контрольную группу составили 28 пациентов без осложнений; в 1-ю группу вошли девять пациентов, у которых диагностирована оппор-тунистическая вирусная инфекция; во 2-ю группу включены семь пациентов с активацией вируса гепатита В или С в трансплантате печени. Провели анализ результатов биохимических и иммунологических исследований у пациентов по группам. Выявлены достоверные различия в изменениях иммунологических показателей у пациентов в группах с инфекцией, вызванной вирусами разных семейств.</p></abstract><trans-abstract xml:lang="en"><p>We observed 44 patients during the first 2 – 3 weeks after liver transplantation. Depending on the postoperative course all patients were divided into 3 groups: control group consisted of 28 patients without complications, group 1 consisted of 9 patients diagnosed with an opportunistic viral infection; group 2 included 7 patients with the activation of viral hepatitis B or C in liver transplant . We analyzed the results of biochemical and immunological studies in all groups of patients. There were significant differences in changes in immunological parameters in the groups of patients with infection caused by viruses of different families.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>трансплантация</kwd><kwd>иммунный ответ</kwd><kwd>лимфоциты</kwd><kwd>вирусная инфекция</kwd></kwd-group><kwd-group xml:lang="en"><kwd>transplantation</kwd><kwd>immune response</kwd><kwd>lymphocytes</kwd><kwd>viral infection</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Трансплантация органов и тканей в многопрофильном научном центре/подред. М.Ш.Хубутия. – М. : АирАрт, 2011. – 420 с.</mixed-citation><mixed-citation xml:lang="en">Трансплантация органов и тканей в многопрофильном научном центре/подред. М.Ш.Хубутия. – М. : АирАрт, 2011. – 420 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Иммунологические исследования при трансплантации печени: роль в дифференциальной диагностике инфекционного воспалительного процесса и острого отторжения / В. П. Никулина [и др.] // Рос. аллерг. жур. – 2011. – №4, вып. 1. – С. 262–264.</mixed-citation><mixed-citation xml:lang="en">Иммунологические исследования при трансплантации печени: роль в дифференциальной диагностике инфекционного воспалительного процесса и острого отторжения / В. П. Никулина [и др.] // Рос. аллерг. жур. – 2011. – №4, вып. 1. – С. 262–264.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Hammerich, L. Role of IL-17 and Th17 cells in liver diseases [Электронный ресурс] / L. Hammerich, F. Heymann, F. Tacke // Clin.Dev. Immunol. – 2011. – Режим доступа: http://www.ncbi.nlm. nih.gov / pmc / articles / PMC3010664 /</mixed-citation><mixed-citation xml:lang="en">Hammerich, L. Role of IL-17 and Th17 cells in liver diseases [Электронный ресурс] / L. Hammerich, F. Heymann, F. Tacke // Clin.Dev. Immunol. – 2011. – Режим доступа: http://www.ncbi.nlm. nih.gov / pmc / articles / PMC3010664 /</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Th17 responses and host defense against microorganisms: an overview / F.L. Van de Veerdonk [et al.] // BMB Rep. – 2009. – Vol. 42 (12). – P. 776–787.</mixed-citation><mixed-citation xml:lang="en">Th17 responses and host defense against microorganisms: an overview / F.L. Van de Veerdonk [et al.] // BMB Rep. – 2009. – Vol. 42 (12). – P. 776–787.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection / I.G. Rodrigue-Gervais [et al.] // J. Immunol. – 2010. – Vol. 184 (6). – P. 3134–3144.</mixed-citation><mixed-citation xml:lang="en">Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection / I.G. Rodrigue-Gervais [et al.] // J. Immunol. – 2010. – Vol. 184 (6). – P. 3134–3144.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms / D.K. Krishnadas [et al.] // Int. Immunol. – 2010. – Vol. 22 (6). – P. 491–502.</mixed-citation><mixed-citation xml:lang="en">Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms / D.K. Krishnadas [et al.] // Int. Immunol. – 2010. – Vol. 22 (6). – P. 491–502.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Schneider-Schaulies, S. Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression / S. Schneider-Schaulies, U. Dittmer // J. Gen. Virol. – 2006. – Vol. 87 (Pt. 6). – P. 1423–1438.</mixed-citation><mixed-citation xml:lang="en">Schneider-Schaulies, S. Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression / S. Schneider-Schaulies, U. Dittmer // J. Gen. Virol. – 2006. – Vol. 87 (Pt. 6). – P. 1423–1438.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Increased hepatitis C virus (HCV) – specific CD4+CD25+regulatory T-lymphocytes and reduced HCV-specific CD4+ T cell response in HCVinfected patients with normal versus abnormal alanine aminotransferase levels / F. Bolacchi [et al.] // Clin. Experiment. Immunol. – 2006. – Vol. 144 (2). – P. 188–196.</mixed-citation><mixed-citation xml:lang="en">Increased hepatitis C virus (HCV) – specific CD4+CD25+regulatory T-lymphocytes and reduced HCV-specific CD4+ T cell response in HCVinfected patients with normal versus abnormal alanine aminotransferase levels / F. Bolacchi [et al.] // Clin. Experiment. Immunol. – 2006. – Vol. 144 (2). – P. 188–196.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C / J.P. Wang [et al.] // APMIS. – 2010. – Vol. 118 (4). – P. 261–270.</mixed-citation><mixed-citation xml:lang="en">Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C / J.P. Wang [et al.] // APMIS. – 2010. – Vol. 118 (4). – P. 261–270.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ярилин, А. А. Транскрипционные регуляторы дифференцировки Т-хелперов. Обзор / А.А. Ярилин // Иммунология. – 2010. – №3. – С. 153–162.</mixed-citation><mixed-citation xml:lang="en">Ярилин, А. А. Транскрипционные регуляторы дифференцировки Т-хелперов. Обзор / А.А. Ярилин // Иммунология. – 2010. – №3. – С. 153–162.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Abbas, A. K. Basic Immunology. Function and Disordes of the Immune System / A. K. Abbas, A.H. Lichtman. – 3rd ed. – Philadelphia : Sanuders, 2009. – 322 p.</mixed-citation><mixed-citation xml:lang="en">Abbas, A. K. Basic Immunology. Function and Disordes of the Immune System / A. K. Abbas, A.H. Lichtman. – 3rd ed. – Philadelphia : Sanuders, 2009. – 322 p.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Increased hepatitis C virus (HCV) – specific CD4+CD25+regulatory T-lymphocytes and reduced HCVspecific CD4+ T cell response in HCVinfected patients with normal versus abnormal alanine aminotransferase levels / F. Bolacchi [et al.] // Clin. Exp. Immunol. – 2006. – Vol. 144 (2). – P. 188–196.</mixed-citation><mixed-citation xml:lang="en">Increased hepatitis C virus (HCV) – specific CD4+CD25+regulatory T-lymphocytes and reduced HCVspecific CD4+ T cell response in HCVinfected patients with normal versus abnormal alanine aminotransferase levels / F. Bolacchi [et al.] // Clin. Exp. Immunol. – 2006. – Vol. 144 (2). – P. 188–196.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Preferential loss of Th17 cells is associated with CD4 T cell activation in patients with 2009 pandemic H1N1 swineorigin influenza A infection / T. J. Jiang [et al.] // Clin. Immunol. – 2010. – Vol. 137 (3). – P. 303–310.</mixed-citation><mixed-citation xml:lang="en">Preferential loss of Th17 cells is associated with CD4 T cell activation in patients with 2009 pandemic H1N1 swineorigin influenza A infection / T. J. Jiang [et al.] // Clin. Immunol. – 2010. – Vol. 137 (3). – P. 303–310.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism / A. Benson [et al.] // J. Immunol. – 2012. – Vol. 188 (2). – P. 800–810.</mixed-citation><mixed-citation xml:lang="en">Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism / A. Benson [et al.] // J. Immunol. – 2012. – Vol. 188 (2). – P. 800–810.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ярилин, А. А. Основы иммунологии / А. А. Ярилин. – М. : Медицина, 1999. – 607 с.</mixed-citation><mixed-citation xml:lang="en">Ярилин, А. А. Основы иммунологии / А. А. Ярилин. – М. : Медицина, 1999. – 607 с.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Пинегин, Б.В. Макрофаги: свойства и функции / Б.В. Пинегин, М. И. Карсонова // Иммунология. – 2009. – №4. – С. 241–249.</mixed-citation><mixed-citation xml:lang="en">Пинегин, Б.В. Макрофаги: свойства и функции / Б.В. Пинегин, М. И. Карсонова // Иммунология. – 2009. – №4. – С. 241–249.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Nel, A. E. Активация Т-лимфоцитов, опосредованная рецептором антигена. Часть II. Роль сигнальных каскадов в дифференцировке Т-лимфоцитов, анергии, иммунологическом старении; их значение для иммунотерапии / A.E. Nel, N. Slaughter // Аллергология и иммунология. – 2004. – Т. 5, №2. – С. 233–248.</mixed-citation><mixed-citation xml:lang="en">Nel, A. E. Активация Т-лимфоцитов, опосредованная рецептором антигена. Часть II. Роль сигнальных каскадов в дифференцировке Т-лимфоцитов, анергии, иммунологическом старении; их значение для иммунотерапии / A.E. Nel, N. Slaughter // Аллергология и иммунология. – 2004. – Т. 5, №2. – С. 233–248.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Organ Transplantation / eds. F. P. Stuart, M. M. Abecassis, D. B. Kaufman. – 2nd ed. – Georgetown, Texas : Landes Bioscience, 2003. – 619 p.</mixed-citation><mixed-citation xml:lang="en">Organ Transplantation / eds. F. P. Stuart, M. M. Abecassis, D. B. Kaufman. – 2nd ed. – Georgetown, Texas : Landes Bioscience, 2003. – 619 p.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Симонова, А. В. Фенотип лимфоцитов при инфекционных заболеваниях человека / А. В. Симонова // Иммунология. – 2002. – №5. – С. 310–313.</mixed-citation><mixed-citation xml:lang="en">Симонова, А. В. Фенотип лимфоцитов при инфекционных заболеваниях человека / А. В. Симонова // Иммунология. – 2002. – №5. – С. 310–313.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Hepatitis C virus (HCV) – specific CD8+ cells produce transforming growth factor beta that can suppress HCVspecific T-cell responses / N. Alatrakchi [et al.] // J. Virol. 2007. – Vol. 81 (1). – P. 5882–5892.</mixed-citation><mixed-citation xml:lang="en">Hepatitis C virus (HCV) – specific CD8+ cells produce transforming growth factor beta that can suppress HCVspecific T-cell responses / N. Alatrakchi [et al.] // J. Virol. 2007. – Vol. 81 (1). – P. 5882–5892.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-nonselfrecognition / M. Rist [et al.] // Blood. – 2009. – Vol. 114 (11). – P. 2244–2253.</mixed-citation><mixed-citation xml:lang="en">Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-nonselfrecognition / M. Rist [et al.] // Blood. – 2009. – Vol. 114 (11). – P. 2244–2253.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation / J.P. Casazza [et al.] // J.Exp. Med. – 2006. – Vol. 203 (13). – P. 2865–2877.</mixed-citation><mixed-citation xml:lang="en">Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation / J.P. Casazza [et al.] // J.Exp. Med. – 2006. – Vol. 203 (13). – P. 2865–2877.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Пащенков, М. В. Выявление и характеризация цитолитических CD8+ и CD4+ Т-клеток / М. В. Пащенков, Н.Е. Муругина, Б. В. Пинегин // Иммунология. – 2010. – №1. – С. 4–12.</mixed-citation><mixed-citation xml:lang="en">Пащенков, М. В. Выявление и характеризация цитолитических CD8+ и CD4+ Т-клеток / М. В. Пащенков, Н.Е. Муругина, Б. В. Пинегин // Иммунология. – 2010. – №1. – С. 4–12.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Пащенков, М. В. Изучение условий дифференцировки CD4+- цитотоксических Т-лимфоцитов / М. В. Пащенков, Б. В. Пинегин // Рос. аллерг. жур. – 2011. – №4, вып. 1. – С. 284–286.</mixed-citation><mixed-citation xml:lang="en">Пащенков, М. В. Изучение условий дифференцировки CD4+- цитотоксических Т-лимфоцитов / М. В. Пащенков, Б. В. Пинегин // Рос. аллерг. жур. – 2011. – №4, вып. 1. – С. 284–286.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
